The transaction includes a 55000000 USD purchase price paid over five years, including an initial 10000000 USD payment at closing, plus up to 95000000 USD in contingent payments based on future performance. Herbalife also obtained a call option to acquire Bioniq LAB, a separate platform focused on small molecules and peptides. Transaction expected to close in Q2 2026, subject to customary closing conditions and regulatory approvals.
About Bioniq
A UK-based personalized supplements company focused on making health more accessible and actionable. Bioniq offers personalized supplements based on personal questionnaires and blood test data and utilizes a large personalized nutrition database to create unique formulas tailored to individual nutrient deficiencies.
London, United Kingdom
Read Company ProfileFunding Rounds
| Amount | Date | Round | |
|---|---|---|---|
| $150 M | Mar, 2026 | acquisition Current | Viewing |
| $55 M | May, 2026 | acquisition | View |
Frequently Asked Questions
What type of funding round did Bioniq raise?
Bioniq raised a acquisition round.
How much did Bioniq raise in its acquisition?
Bioniq raised $150,000,000 USD in its acquisition.
Who invested in Bioniq's acquisition?
The investors in Bioniq's acquisition are: Herbalife, HV Capital, Unbound, Cristiano Ronaldo, Diogo Dalot.
How will Bioniq use the funds from its acquisition?
Bioniq plans to use the funds for: global scaling of Bioniq's personalised supplementation platform, integration into Herbalife's ecosystem, product innovation, market expansion, enhancing customer experience.